128 related articles for article (PubMed ID: 37125989)
21. Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE
Vasandan AB; Jahnavi S; Shashank C; Prasad P; Kumar A; Prasanna SJ
Sci Rep; 2016 Dec; 6():38308. PubMed ID: 27910911
[TBL] [Abstract][Full Text] [Related]
22. CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection.
Shaheen ZR; Naatz A; Corbett JA
J Immunol; 2015 Nov; 195(9):4406-14. PubMed ID: 26408666
[TBL] [Abstract][Full Text] [Related]
23. Akt, mTOR and NF-κB pathway activation in Treponema pallidum stimulates M1 macrophages.
Lin LR; Gao ZX; Lin Y; Zhu XZ; Liu W; Liu D; Gao K; Tong ML; Zhang HL; Liu LL; Xiao Y; Niu JJ; Liu F; Yang TC
Int Immunopharmacol; 2018 Jun; 59():181-186. PubMed ID: 29656208
[TBL] [Abstract][Full Text] [Related]
24. Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice.
Jiang H; Westerterp M; Wang C; Zhu Y; Ai D
Diabetologia; 2014 Nov; 57(11):2393-404. PubMed ID: 25120095
[TBL] [Abstract][Full Text] [Related]
25. Adipose-derived Mesenchymal Stromal Cells Modulate Lipid Metabolism and Lipid Droplet Biogenesis via AKT/mTOR -PPARγ Signalling in Macrophages.
Souza-Moreira L; Soares VC; Dias SDSG; Bozza PT
Sci Rep; 2019 Dec; 9(1):20304. PubMed ID: 31889120
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
Nishimura Y; Chunthorng-Orn J; Lord S; Musa I; Dawson P; Holm L; Lai YC
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C215-C225. PubMed ID: 35704697
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
28. Prevention of Akt phosphorylation is a key to targeting cancer stem-like cells by mTOR inhibition.
Matsubara S; Tsukasa K; Kuwahata T; Takao S
Hum Cell; 2020 Oct; 33(4):1197-1203. PubMed ID: 32851605
[TBL] [Abstract][Full Text] [Related]
29. CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.
Pacitto R; Gaeta I; Swanson JA; Yoshida S
J Leukoc Biol; 2017 Mar; 101(3):683-692. PubMed ID: 28250113
[TBL] [Abstract][Full Text] [Related]
30. mTORC1 Regulates Flagellin-Induced Inflammatory Response in Macrophages.
Bao W; Wang Y; Fu Y; Jia X; Li J; Vangan N; Bao L; Hao H; Wang Z
PLoS One; 2015; 10(5):e0125910. PubMed ID: 25942007
[TBL] [Abstract][Full Text] [Related]
31. Human umbilical cord mesenchymal stem cells derived exosomes exert antiapoptosis effect via activating PI3K/Akt/mTOR pathway on H9C2 cells.
Liu H; Sun X; Gong X; Wang G
J Cell Biochem; 2019 Sep; 120(9):14455-14464. PubMed ID: 30989714
[TBL] [Abstract][Full Text] [Related]
32. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
33. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
34. Renal tumours in a Tsc2(+/-) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin.
Yang J; Kalogerou M; Samsel PA; Zhang Y; Griffiths DF; Gallacher J; Sampson JR; Shen MH
Oncogene; 2015 Feb; 34(7):922-31. PubMed ID: 24632604
[TBL] [Abstract][Full Text] [Related]
35. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells ameliorate inflammatory cytokine-induced impairment of AT-II cells through a keratinocyte growth factor-dependent PI3K/Akt/mTOR signaling pathway.
Li J; Huang S; Zhang J; Feng C; Gao D; Yao B; Wu X; Fu X
Mol Med Rep; 2016 May; 13(5):3755-62. PubMed ID: 27035760
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotection of resveratrol against cadmium-poisoning acts through dual inhibition of mTORC1/2 signaling.
Liu C; Zhang R; Yang L; Ji T; Zhu C; Liu B; Zhang H; Xu C; Zhang N; Huang S; Chen L
Neuropharmacology; 2022 Nov; 219():109236. PubMed ID: 36049535
[TBL] [Abstract][Full Text] [Related]
38. Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis.
Liao M; Hu F; Qiu Z; Li J; Huang C; Xu Y; Cheng X
Aging (Albany NY); 2021 Sep; 13(18):22412-22431. PubMed ID: 34547720
[TBL] [Abstract][Full Text] [Related]
39. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
40. Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition.
Breuleux M; Klopfenstein M; Stephan C; Doughty CA; Barys L; Maira SM; Kwiatkowski D; Lane HA
Mol Cancer Ther; 2009 Apr; 8(4):742-53. PubMed ID: 19372546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
